Literature DB >> 9661761

Otalgia. An isolated symptom of malignant infratemporal tumors.

J P Leonetti1, J Li, P G Smith.   

Abstract

OBJECTIVE: This study aimed to review a series of 18 patients with malignant infratemporal fossa tumors who presented with otalgia as the primary symptom. STUDY
DESIGN: This was a retrospective case analysis.
SETTING: All patients were evaluated and treated at a tertiary care academic medical institution. PATIENTS: Eighteen patients evaluated for otalgia in a normal-appearing ear, between July 1988 and July 1996, who were found to have a malignant infratemporal fossa tumor participated.
INTERVENTIONS: Diagnostic testing included radiographic evaluations and tissue sampling through fine-needle aspiration cytology. Treatment methods were histology dependent. MAIN OUTCOME MEASURES: The time between the onset of otalgia and the tumor diagnosis was recorded. Overall treatment outcomes were reviewed.
RESULTS: The period between the onset of otalgia and tumor diagnosis ranged from 4-21 months with a mean of 7.5 months. Adenoid cystic carcinoma was the most commonly seen tumor in this series of patients.
CONCLUSIONS: The infratemporal fossa is a relatively protected region that may be the site of malignant neoplasms causing the isolated symptom of otalgia.

Entities:  

Mesh:

Year:  1998        PMID: 9661761

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  1 in total

1.  Diagnostic Yield and Therapeutic Impact of Face and Neck Imaging in Patients Referred with Otalgia without Clinically Overt Disease.

Authors:  E Ainsworth; I Pai; M Kathirgamanathan; S E J Connor
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-24       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.